Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Nolan

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
The Pediatric Infectious Disease Journal|September 16, 2015
Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed ToddlersRobert Booy, Terry Nolan, Graham Reynolds, et al.
Influenza and Other Respiratory Viruses|June 21, 2012
Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trialPeter F Howard, James M McCaw, Peter C Richmond, et al.
Vaccine|May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 yearsHelen Marshall, Terry Nolan, Javier Díez Domingo, et al.
BMC Infectious Diseases|December 13, 2012
Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adultsJames M McCaw, Peter F Howard, Peter C Richmond, et al.
Vaccine|February 1, 2003
Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilitiesTerry Nolan, Min-Shi Lee, Julie M Cordova, et al.
Human Vaccines & Immunotherapeutics|May 24, 2012
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsKristina Bryant, Jodie McVernon, Colin Marchant, et al.
Human Vaccines & Immunotherapeutics|July 8, 2024
4CMenB journey to the 10-year anniversary and beyondVéronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, et al.
The Pediatric Infectious Disease Journal|May 23, 2019
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersTerry Nolan, Robert Booy, Helen S Marshall, et al.
Human Vaccines & Immunotherapeutics|February 14, 2012
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)Stephen Rinderknecht, Kristina Bryant, Terry Nolan, et al.
The Pediatric Infectious Disease Journal|March 10, 2025
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood DosesSonia M McAlister, Anita H J van den Biggelaar, Matthew N Cooper, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
The Pediatric Infectious Disease Journal|September 16, 2015
Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed ToddlersRobert Booy, Terry Nolan, Graham Reynolds, et al.
Influenza and Other Respiratory Viruses|June 21, 2012
Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trialPeter F Howard, James M McCaw, Peter C Richmond, et al.
Vaccine|May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 yearsHelen Marshall, Terry Nolan, Javier Díez Domingo, et al.
BMC Infectious Diseases|December 13, 2012
Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adultsJames M McCaw, Peter F Howard, Peter C Richmond, et al.
Vaccine|February 1, 2003
Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilitiesTerry Nolan, Min-Shi Lee, Julie M Cordova, et al.
Human Vaccines & Immunotherapeutics|May 24, 2012
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsKristina Bryant, Jodie McVernon, Colin Marchant, et al.
Human Vaccines & Immunotherapeutics|July 8, 2024
4CMenB journey to the 10-year anniversary and beyondVéronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, et al.
The Pediatric Infectious Disease Journal|May 23, 2019
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as ToddlersTerry Nolan, Robert Booy, Helen S Marshall, et al.
Human Vaccines & Immunotherapeutics|February 14, 2012
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)Stephen Rinderknecht, Kristina Bryant, Terry Nolan, et al.
The Pediatric Infectious Disease Journal|March 10, 2025
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood DosesSonia M McAlister, Anita H J van den Biggelaar, Matthew N Cooper, et al.
Pageof 10